SCHEMBL27435461

SCHEMBL27435461

CCOC(=O)/C=C/OCCc1cc(Cl)cc2c(=O)n(COCC[Si](C)(C)C)ncc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27077756 0.90 NPC1 (0.31) —
SCHEMBL27077669 0.83 KDM4E (0.33) —
SCHEMBL27077732 0.81 NPC1 (0.33) —
SCHEMBL27435356 0.81 NPC1 (0.32) —
SCHEMBL29987343 0.80 NPC1 (0.34) —
SCHEMBL27435380 0.78 NPC1 (0.34) —
SCHEMBL27077783 0.77 F2RL1 (0.32) —
SCHEMBL27077653 0.76 NPC1 (0.31) —
SCHEMBL29987559 0.74 DGAT1 (0.32) —
SCHEMBL27077755 0.72 NPC1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217968-A1 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2024-07-04 — — US disclosed
US-20240217968-A1 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2024-07-04 — — US disclosed
EP-4313300-A1 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2024-02-07 — — EP disclosed
WO-2022207752-A1 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2022-10-06 — — WO disclosed
Send feedback